SPRC - SciSparc Ltd.

5.99
1.760   29.382%

Share volume: 15,133,837
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.15%

PREVIOUS CLOSE
CHG
CHG%
$4.23
1.76
0.42%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
35.52%
1 Month
32.52%
3 Months
493.07%
6 Months
57.22%
1 Year
2,081.35%
2 Year
1,518.92%
Key data
Stock price
$5.99
P/E Ratio 
N/A
DAY RANGE
$4.68 - $6.57
EPS 
N/A
52 WEEK RANGE
$0.25 - $8.90
52 WEEK CHANGE
$1,987.11
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$2,696,955
AVERAGE 30 VOLUME 
$906,184
Company detail
CEO: Oz Adler
Region: US
Website: scisparc.com
Employees: 4
IPO year: 2021
Issue type:
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

SciSparc Ltd. develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation. SCi-160 for the. treatment of pain; SCII-210 for the. treatment of autism spectrum disorder and epilepsy. The company was formerly known as Therapix Biosciences.

Recent news